Key result
Telehealth-based dietary interventions significantly improved systolic blood pressure (MD -2.74; 95% CI -4.93 to -0.56) and LDL cholesterol (SMD -0.11; 95% CI -0.19 to -0.03) compared to usual care.
Why the study?
Telehealth-based dietary interventions were recommended for CVD management during COVID-19, but data regarding their effectiveness and feasibility are limited.
Meta-Analysis (n=3,013)
Yes
Mean Difference: -2.74 (95% CI -4.93–-0.56)
Clinicians should consider telehealth dietary counseling for BP and lipid management; extends prior in-person evidence to scalable remote delivery.
BACKGROUND Telehealth-based dietary interventions were recommended for cardiovascular disease (CVD) management during the COVID-19 pandemic; however, data regarding their effectiveness and feasibility are limited. OBJECTIVE We aimed to examine (1) the effectiveness of telehealth-based dietary interventions in improving clinical CVD risk factors and (2) the feasibility of these interventions among individuals with CVD. METHODS To conduct this systematic review and meta-analysis of randomized controlled trials (RCTs), 2 investigators searched PubMed, Cochrane Library, Web of Science, and ClinicalTrials.gov databases based on predetermined search terms and included English-language RCTs published between January 2000 and July 2022. The Cochrane Risk of Bias tool was used to assess RCT quality. To evaluate intervention effectiveness, weight, BMI, systolic and diastolic blood pressure, and levels of total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, or blood glucose were compared postintervention in telehealth and usual care (UC) groups. Feasibility was determined through the number of participants retained in intervention and UC groups. Pooled data for each CVD outcome were analyzed using a random effects model. Mean difference (MD), standardized MD, or risk ratio were calculated using R software. RESULTS A total of 13 RCTs with 3013 participants were included in the analysis to assess the effectiveness and feasibility of telehealth-based dietary interventions among individuals with CVD. Participants had a mean age of 61.0 (SD 3.7) years, and 18.5% (n=559) were women. Approximately one-third of RCTs were conducted in the United States (n=4, 31%). Included studies used telephone, app, text, audio-visual media, or website-based interventions. Of the 13 included studies, 3 were of high quality, 9 were of moderate quality, and only 1 was of low quality. Pooled estimates showed systolic blood pressure (MD –2.74, 95% CI –4.93 to –0.56) and low-density lipoprotein cholesterol (standardized MD –0.11, 95% CI –0.19 to –0.03) to be significantly improved among individuals with CVD as a result of telehealth-based dietary interventions compared to UC. No significant difference in effectiveness was detected for weight, BMI, and levels of diastolic blood pressure, total cholesterol, high-density lipoprotein, and triglycerides between telehealth-based dietary interventions and UC among those with CVD. There was no significant difference between the feasibility of telehealth-based dietary interventions versus UC. Significant I² indicated moderate to considerable heterogeneity. CONCLUSIONS Telehealth-based dietary interventions show promise in addressing CVD risk factors.
No takes yet. Share an insight, caveat, or question.
Trivedi et al. (2023) conducted a meta-analysis in Cardiovascular disease (n=3,013). Telehealth-based dietary interventions vs. Usual care was evaluated on Systolic blood pressure (MD -2.74, 95% CI -4.93 to -0.56). Telehealth-based dietary interventions significantly improved systolic blood pressure (MD -2.74; 95% CI -4.93 to -0.56) and LDL cholesterol (SMD -0.11; 95% CI -0.19 to -0.03) compared to usual care.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: